Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 215186
Company: TASMAN PHARMA
Company: TASMAN PHARMA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | OINTMENT;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/18/2022 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
BETAMETHASONE DIPROPIONATE
OINTMENT;TOPICAL; EQ 0.05% BASE
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | OINTMENT;TOPICAL | Prescription | No | AB | 071012 | ACTAVIS MID ATLANTIC |
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | OINTMENT;TOPICAL | Prescription | Yes | AB | 019141 | FOUGERA PHARMS INC |
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | OINTMENT;TOPICAL | Prescription | No | AB | 215847 | PADAGIS ISRAEL |
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | OINTMENT;TOPICAL | Prescription | No | AB | 074271 | TARO |
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | OINTMENT;TOPICAL | Prescription | No | AB | 215186 | TASMAN PHARMA |
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | OINTMENT;TOPICAL | Prescription | No | AB | 214048 | ZYDUS LIFESCIENCES |